ADL5945, a potent orally bioavailable peripheral opioid receptor antagonist, improves bowel motility w/a low incidence/severity of GI AEs in a dose-dependent manner: results of 2 Ph 2 trials in opioid-induced constipation pts (45CL242 and 45CL243)
L. Techner, N. Singla, K. Gabriel, R. ManganoVolume:
13
Year:
2012
Language:
english
DOI:
10.1016/j.jpain.2012.01.349
File:
PDF, 34 KB
english, 2012